Bevacizumab Biosimilar Vial for Oncology
Avastin biosimilar bevacizumab, a VEGF monoclonal antibody in 100mg/4ml vials for retail infusion in cancer treatment, modulating angiogenesis via immune regulation. Fits HTS 3002.15.00.91 for MAB immunological products in measured doses.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If as organometallic antibiotic complex
Certain mixed organometallics classify under 3003 per notes.
If for waste or expired product
Chapter note (k) moves unfit pharmaceuticals to 3006.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Biosimilars need comparative efficacy data; FDA 351(k) pathway docs essential
• Use insulated packaging with data loggers for uninterrupted cold chain
Related Products under HTS 3002.15.00.91
Monoclonal Antibody Infusion Kit for Rheumatoid Arthritis
This kit contains rituximab, a monoclonal antibody, pre-filled in measured-dose syringes for intravenous infusion to treat rheumatoid arthritis. It qualifies under HTS 3002.15.00.91 as an immunological product (peptide/protein regulating immunological processes) put up in measured doses for retail sale. Biotechnologically produced and modified for therapeutic use.
Interferon Beta-1a Injection for Multiple Sclerosis
Prefilled syringes of recombinant interferon beta-1a, an immunological protein for modulating immune response in MS patients, packaged in retail-ready measured doses. Falls under HTS 3002.15.00.91 per chapter notes defining immunological products as proteins like interferons in retail forms.
Adalimumab Prefilled Syringe for Psoriasis Treatment
Humira-brand adalimumab, a TNF inhibitor monoclonal antibody in 40mg prefilled syringes for retail sale, used prophylactically against autoimmune psoriasis flares. Classified in HTS 3002.15.00.91 as a biotechnological immunological product in measured retail doses.
Interleukin-2 Injection for Melanoma Therapy
Recombinant human IL-2 in single-dose vials for retail, an immunological cytokine stimulating T-cell response in cancer immunotherapy. HTS 3002.15.00.91 applies as it matches chapter note for interleukins as immunological products in measured retail packs.
Denosumab Injection for Osteoporosis
Prolia-brand denosumab, RANKL inhibitor antibody in 60mg prefilled syringes for retail, preventing bone resorption through immunological modulation. HTS 3002.15.00.91 for antibody-based immunological products in retail measured forms.